Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease

Clinical trial NCT00632359 · COMPLETED

Trial details

NCT number: NCT00632359
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2008-02-01
Primary completion: 2015-10-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.